Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer
- PMID: 35267622
- PMCID: PMC8909171
- DOI: 10.3390/cancers14051314
Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer
Abstract
Metastasis remains the main cause of death for breast cancer (BC) patients, and conceivably, a huge effort has been directed toward the understanding of the metastatic process [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.Breast Cancer Res Treat. 2021 Aug;189(1):63-80. doi: 10.1007/s10549-021-06299-0. Epub 2021 Jul 3. Breast Cancer Res Treat. 2021. PMID: 34216317
-
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.Int J Mol Sci. 2020 Mar 2;21(5):1696. doi: 10.3390/ijms21051696. Int J Mol Sci. 2020. PMID: 32121639 Free PMC article. Review.
-
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.J Transl Med. 2012 Mar 8;10:42. doi: 10.1186/1479-5876-10-42. J Transl Med. 2012. PMID: 22400902 Free PMC article.
-
Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.J Clin Lab Anal. 2021 Aug;35(8):e23887. doi: 10.1002/jcla.23887. Epub 2021 Jul 15. J Clin Lab Anal. 2021. PMID: 34264524 Free PMC article.
-
The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.Breast Cancer Res Treat. 2019 Jun;175(2):277-286. doi: 10.1007/s10549-019-05159-2. Epub 2019 Feb 27. Breast Cancer Res Treat. 2019. PMID: 30810866 Review.
Cited by
-
Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis?Cancers (Basel). 2024 Feb 17;16(4):816. doi: 10.3390/cancers16040816. Cancers (Basel). 2024. PMID: 38398206 Free PMC article. Review.
References
-
- Cristofanilli M., Pierga J.Y., Reuben J., Rademaker A., Davis A.A., Peeters D.J., Fehm T., Nole F., Gisbert-Criado R., Mavroudis D., et al. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. Crit. Rev. Oncol. Hematol. 2019;134:39–45. doi: 10.1016/j.critrevonc.2018.12.004. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources